Home
Company Profile
Technology and Approach
Targeted Diseases
Company News
- Press Releases
- Publications
- In the Media
- Q & A
- Awards
- Blog
Clinical Outcomes Improvement
Clinical Trials
Questions & Answers
Email Alerts
Contact Us
GenoMed, Inc.
9666 Olive Blvd.
Suite 310
St. Louis, MO 63132
United States of America
314-983-9933
Publications
From Pharmacogenomics to Improved Patient Outcomes: Angiotensin I-Converting Enzyme as an Example
Is Angiotensin I-Converting Enzyme a "Master" Disease Gene?
Is "Somatic" Angiotensin I-Converting Enzyme a Mechanosensor?
Pathophysiologic Implications of Angiotensin I-Converting Enzyme as a Mechanosensor: Diabetes
Why AT1R blockade makes sense for SARS
The Central Role of Angiotensin I-Converting Enzyme in Vertebrate Pathophysiology
Written evidence
to the House of Lords Science and Technology Committee,
Sub-Committee II on Genomic Medicine
Are Blockbuster Drugs Still Possible in the Era of Personalized Medicine?
A Modern-Day Tuskegee... and What's Really Wrong with U.S. Health Care Today?
© 2001-2010 GenoMed. All rights reserved.
Powered by
InvoDesign